GlassScriptPhysician profile
Brian M Litch
NPI 1538141262
$4,645.80
in general payments reported to CMS, 2019-2025
29 companies · $29.85 in 2025
The $29.85 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $580 · 2020: $169 · 2021: $521 · 2022: $698 · 2023: $1,475 · 2024: $1,173 · 2025: $29.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,678.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,677.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $963.39 | 2019-2024 | Aveir, Pressurewire, Jot Dx |
| Kestra Medical Technology Services, INC. | $503.15 | 2023-2024 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $401.50 | 2019-2024 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $354.29 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $343.05 | 2020-2024 | |
| Angiodynamics, INC. | $264.45 | 2023-2024 | Alphavac, Angiovac, Auryon Laser System 100-120 Vac |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $248.42 | 2019-2024 | Lifevest |
| Amgen INC. | $247.70 | 2019-2024 | Repatha |
| Astellas Pharma US INC | $198.00 | 2021 | |
| Pfizer INC. | $160.80 | 2022-2024 | |
| Cardiovascular Systems INC. | $148.89 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.11 | 2022-2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $103.55 | 2019-2024 | Wainua, Farxiga |
| Kiniksa Pharmaceuticals International, Plc | $88.54 | 2024 | Arcalyst |
| Kiniksa Pharmaceuticals, LTD. | $77.83 | 2023 | Arcalyst |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $76.31 | 2023-2025 | Watchman Flx, Watchman Access System |
| Actelion Pharmaceuticals US, INC. | $51.40 | 2023-2024 | Uptravi, Opsumit |
| Impulse Dynamics (USA) INC. | $46.99 | 2022 | |
| Scpharmaceuticals INC. | $34.48 | 2023 | |
| Irhythm Technologies, INC. | $31.21 | 2023 | Zio Xt Patch |
| Cardinal Health 200 LLC | $29.56 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $27.23 | 2019 | |
| Novo Nordisk INC | $23.43 | 2024 | Wegovy |
| Siemens Medical Solutions USA, INC. | $19.13 | 2023 | Acuson Sc2000 Diagnostic Ultrasound System, Artis Q Ceiling, Symbia_intevo_bold |
| Philips North America LLC | $18.80 | 2023 | |
| Daiichi Sankyo INC. | $18.59 | 2023 | Injectafer |
| Abiomed | $14.04 | 2023 | Impella |
| Esperion Therapeutics, INC. | $13.25 | 2020 | |
| Gilead Sciences, INC. | $12.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Litch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.